Kevin Fischbeck
Stock Analyst at B of A Securities
(3.98)
# 601
Out of 4,996 analysts
183
Total ratings
64.62%
Success rate
6.09%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $18.87 | -4.61% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $130.80 | +7.03% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $202.00 | +11.39% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $126.70 | +26.28% | 2 | Sep 10, 2025 | |
| HUM Humana | Maintains: Neutral | $285 → $312 | $254.95 | +22.38% | 16 | Sep 2, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $290 → $325 | $344.08 | -5.55% | 26 | Aug 18, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $13.26 | +10.11% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $34.86 | -13.94% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $200.85 | -7.89% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $419.08 | -2.17% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $33 | $24.53 | +34.53% | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $1.09 | +175.23% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $318.61 | +66.35% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $191.98 | +128.67% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $8.89 | -26.88% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $17.53 | -58.64% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $286.17 | +22.30% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.84 | +106.04% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.18 | +72.96% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.64 | +176.90% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.20 | +212.50% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $14.23 | -47.29% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $27.30 | -34.07% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $16.30 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $33.29 | -42.93% | 2 | Feb 9, 2018 |
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $18.87
Upside: -4.61%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $130.80
Upside: +7.03%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $202.00
Upside: +11.39%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $126.70
Upside: +26.28%
Humana
Sep 2, 2025
Maintains: Neutral
Price Target: $285 → $312
Current: $254.95
Upside: +22.38%
UnitedHealth Group
Aug 18, 2025
Maintains: Neutral
Price Target: $290 → $325
Current: $344.08
Upside: -5.55%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $13.26
Upside: +10.11%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $34.86
Upside: -13.94%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $200.85
Upside: -7.89%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $419.08
Upside: -2.17%
May 13, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $24.53
Upside: +34.53%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.09
Upside: +175.23%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $318.61
Upside: +66.35%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $191.98
Upside: +128.67%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $8.89
Upside: -26.88%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $17.53
Upside: -58.64%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $286.17
Upside: +22.30%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.84
Upside: +106.04%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.18
Upside: +72.96%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.64
Upside: +176.90%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.20
Upside: +212.50%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $14.23
Upside: -47.29%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $27.30
Upside: -34.07%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $16.30
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $33.29
Upside: -42.93%